Browsing Vanderbilt Ingram Cancer Center by Title
Now showing items 3-7 of 7
-
(British Journal of Cancer, 2019-08-27)
-
(Blood Cancer Journal, 2019-03-29)This phase I dose-escalation/expansion study evaluated isatuximab (anti-CD38 monoclonal antibody) monotherapy in patients with relapsed/refractory multiple myeloma (RRMM). Patients progressing on or after standard therapy ...
-
(Annals of Surgical Oncology, 2019-10)Background Breast cancer-related lymphedema (BCRL) represents a major source of morbidity among breast cancer survivors. Increasing data support early detection of subclinical BCRL followed by early intervention. A randomized ...
-
(2019-12-11)Background: In medical oncology settings, early specialist palliative care interventions have demonstrated improvements in patient quality of life and survival compared with usual oncologic care. However, the effect of ...
-
(Clinical Lymphoma Myeloma & Leukemia, 2019-09)Approximately half of the patients with polycythemia vera experience substantial symptom burdens. We analyzed data from the ongoing Prospective Observational Study of Patients with Polycythemia Vera in US Clinical Practices ...